ArticleCancer immunology, immunotherapy : CII2023

Dominant-negative transforming growth factor-β receptor-armoured mesothelin-targeted chimeric antigen receptor T cells slow tumour growth in a mouse model of ovarian cancer.

Ke Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.